1 citations
,
September 2016 in “Hair transplant forum international” This article proposes enhancing the Norwood-Hamilton scale for assessing hair loss patterns but reports no new clinical results.
1 citations
,
June 1990 in “PubMed” This study in Chinese patients with male pattern baldness found that 2% minoxidil solution led to moderate hair growth in 22% of participants and was generally well-tolerated.
1 citations
,
March 1990 in “Clinical Drug Investigation” 2% topical minoxidil can help reduce hair loss and promote hair growth in male pattern baldness.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review examined a polyherbal hair formulation aimed at managing male pattern baldness, reporting that its ingredients may enhance scalp blood circulation, strengthen hair follicles, and promote hair regrowth through various mechanisms such as antioxidant and DHT-inhibiting effects.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review examines a polyherbal hair oil formulation containing ingredients like Amla and Pumpkin seed oil, reporting potential benefits for managing male pattern baldness through antioxidant, anti-inflammatory, and DHT-inhibiting properties, alongside improved scalp blood circulation and hair regrowth.
July 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review reports on a polyherbal hair formulation developed to manage male pattern baldness, highlighting its potential to enhance scalp blood circulation, strengthen hair follicles, and promote hair regrowth through antioxidant, anti-inflammatory, and DHT-inhibiting mechanisms.
July 2026 in “European Urology Focus” This study found a significant association between baldness patterns, particularly vertex and early-onset baldness, and an increased risk of prostate cancer.
This study reviews the use of natural products, like herbal extracts and essential oils, in treating male pattern baldness, noting their potential benefits compared to conventional therapies that may carry side effects or ethical concerns.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review highlights a polyherbal hair formulation that combines various natural ingredients, reporting potential benefits in improving scalp circulation, strengthening hair, and promoting regrowth, which might offer a safer alternative for managing male pattern baldness compared to synthetic drugs.
Minoxidil and finasteride are recommended for male pattern baldness.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Minoxidil and finasteride are recommended for male pattern baldness.
February 2026 in “International Journal of Molecular Sciences” In this study, researchers identified 47 proteins associated with male pattern baldness severity and prioritized five candidate genes, including druggable CD38, suggesting new non-hormonal targets for therapeutic development.
January 2026 in “Medico Research Chronicles” This case report suggests that a classical homeopathic approach at Dr Batra’s® Homeopathy Clinic significantly improved hair fall, hair density, and quality of life for a young male with Grade III Male Pattern Baldness over 18 months.
January 2026 in “Dermatologic Therapy” This study found that a novel topical dutasteride lotion, FOL100, demonstrated excellent safety, tolerability, and usability with promising signs of clinical benefit for mild-to-moderate male pattern baldness.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study explores a novel hypothesis for Male Pattern Baldness, suggesting that chronic tension in the scalp's Galea Aponeurotica creates a hypoxic environment affecting hair follicles, and proposes a Triad Therapeutic Protocol to address this underlying cause rather than just the symptoms.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This paper identifies Galeal Tension-Induced Follicular Hypoxia as a mechanism for male pattern baldness, proposing a new therapeutic protocol targeting underlying physiological failures rather than just symptoms.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study elucidates a mechanism for male pattern baldness involving chronic scalp tension leading to follicular hypoxia, rather than purely hormonal factors, and proposes a treatment targeting electrolyte, vascular, and neurological factors to restore balance.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study elucidates a mechanism for male pattern baldness involving tension in scalp muscles that leads to reduced blood flow and hypoxia around hair follicles, proposing a multi-targeted therapeutic approach.
July 2025 in “AACE Endocrinology and Diabetes” Ovarian hyperthecosis caused high testosterone and virilization symptoms in a 60-year-old woman, which improved after surgery.
The research examined Crown-X, a novel formulation containing Menstrual Stem Cells, and found that it promoted significant proliferation of human dermal papilla cells, suggesting its potential as a non-invasive treatment for male pattern baldness. Future clinical trials are necessary to confirm its efficacy.
April 2025 in “International Journal of Homoeopathic Sciences” This case report described a 29-year-old man with male pattern baldness treated with the lesser-known sarcode Adrenalin, but the abstract does not provide further details on the treatment outcome or efficacy.
December 2024 in “International Journal of Drug Delivery Technology” In this study, researchers developed and evaluated a topical dutasteride gel for treating male pattern baldness, finding that a formulation with 10% garlic extract showed the most promising results in promoting faster hair growth compared to other formulations tested.
September 2024 in “Frontiers in Genetics” In this study, researchers found a significant association between the rs13405699 SNP at 2q31.1 and male pattern baldness among Han Chinese men, suggesting genetic influence on this condition in this population.
In a double-blind, randomized study with 68 Brazilian men, oral minoxidil was found to be as effective as topical minoxidil 5% in treating androgenetic alopecia, or male pattern baldness.
Toupees improved perceived attractiveness, especially by older people, but had little effect on perceived self-assurance and health.
The abstract indicates that the paper addresses social perceptions of males, but no specific research findings or results are reported.
The review suggests the study on male pattern baldness needs to improve in areas like sample size, methodology, and bias for better quality and credibility.
April 2024 in “Human genomics” This study identified MPB susceptibility genes and potential drug candidates that may help uncover molecular mechanisms and address male-pattern baldness.
In this study, 13 men with male pattern baldness were rated significantly more attractive and somewhat healthier when wearing a custom-made toupee, with higher attractiveness ratings coming from male judges than female judges.
January 2024 in “Research Square (Research Square)” This study identified robust susceptibility genes and potential drug candidates for male-pattern baldness, providing insights into the condition's molecular mechanisms.